Health Canada drug identification number

DIN 02358840 — ACT RALOXIFENE 60 MG

ACT RALOXIFENE is a tablet of Raloxifene marketed by TEVA CANADA LIMITED. The full Raloxifene monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02358840
Brand name
ACT RALOXIFENE
Active ingredient
Raloxifene
Strength
60 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
TEVA CANADA LIMITED
Health Canada status
MARKETED
Drug class
Selective estrogen receptor modulator (SERM)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Raloxifene products

DINBrandStrengthFormManufacturerStatus
02279215 APO-RALOXIFENE 60 MG TABLET APOTEX INC MARKETED
02540681 JAMP RALOXIFENE 60 MG TABLET JAMP PHARMA CORPORATION MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.